Tryptophan: From Diet to Cardiovascular Diseases |
| |
Authors: | Nada Joe Melhem Soraya Taleb |
| |
Affiliation: | Paris Cardiovascular Research Center, Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Descartes, 75015 Paris, France; |
| |
Abstract: | Cardiovascular disease (CVD) is one of the major causes of mortality worldwide. Inflammation is the underlying common mechanism involved in CVD. It has been recently related to amino acid metabolism, which acts as a critical regulator of innate and adaptive immune responses. Among different metabolites that have emerged as important regulators of immune and inflammatory responses, tryptophan (Trp) metabolites have been shown to play a pivotal role in CVD. Here, we provide an overview of the fundamental aspects of Trp metabolism and the interplay between the dysregulation of the main actors involved in Trp metabolism such as indoleamine 2, 3-dioxygenase 1 (IDO) and CVD, including atherosclerosis and myocardial infarction. IDO has a prominent and complex role. Its activity, impacting on several biological pathways, complicates our understanding of its function, particularly in CVD, where it is still under debate. The discrepancy of the observed IDO effects could be potentially explained by its specific cell and tissue contribution, encouraging further investigations regarding the role of this enzyme. Thus, improving our understanding of the function of Trp as well as its derived metabolites will help to move one step closer towards tailored therapies aiming to treat CVD. |
| |
Keywords: | tryptophan tryptophan catabolism kynurenine IDO cardiovascular disease atherosclerosis myocardial infarction cardiometabolic diseases |
|
|